Status:
COMPLETED
The FGF/FGFR Signalling Pathway:
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Liposarcoma
Eligibility:
All Genders
18+ years
Brief Summary
Liposarcomas are the most common type of soft tissue sarcomas (STS). Among liposarcomas, well-differentiated liposarcoma (WDLPS)/dedifferentiated liposarcoma (DDLPS) are the most frequent types. WDLPS...
Eligibility Criteria
Inclusion
- A biopsy and\\or an exérèse with diagnostic or curative aim will have been practised within the framework of a well differentiated liposarcome or dédifférencié with development of the gene MDM2
- A taking of the tumor is available (frozen fragment and\\or block fixed in paraffin wax) - not opposition of the patient will have been looked for
Exclusion
- Liposarcome not differentiated
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2019
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT03303885
Start Date
October 1 2017
End Date
March 29 2019
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice Hospital
Nice, France, 06000